You just read:

Eiger BioPharmaceuticals Announces License of Worldwide Rights to Pegylated Interferon Lambda-1a from Bristol-Myers Squibb

News provided by

Eiger BioPharmaceuticals, Inc.

Apr 20, 2016, 16:30 ET